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ABSTRACT 
Background: Maternal measles antibodies (MMA) are actively transferred in mother-infant pairs during third trimester of 
pregnancy. Gestational age (GA) affects the levels of MMA such that longer GA may result in infants starting out with high 
levels of MMA. 
Objective: To determine the influence of GA on the loss of MMA in newborn infants in North-Eastern Nigeria. 
Method: A prospective study was conducted on newborn infants at Maiduguri; sera were collected at birth and at six months of 
age. Enzyme linked immunosorbent assay (ELISA) was used to measure MMA while GA was determined using the last 
menstrual period, ultrasound scan reports and the Dubowitz criteria. 
Results: Seventy eight newborn infants were enrolled. Seventeen (89.5 %) preterm, 43 (95.6 %) term and 14 (100 %) postterm had 
protective levels of MMA at birth. Two (10.5 %) preterm, nine (20.0%) term and two (14.3 %) postterm had protective MMA at six 
months of age. Comparison of mean MMA at birth and at six months of age was significant (p = 0.005), however, it was 
independent of GA of the newborn infants. 
Conclusion: Significant decline of mean MMA levels was seen in these infants at six months of age, which was independent of 
their GA. These infants may be prone to measles at an earlier age (less than six months). Therefore, the current recommendation 
of measles immunization to infants at nine months of age may require reconsideration. 
Keywords: maternal measles antibodies, gestational age, measles immunization, newborn infants. 
INTRODUCTION 
Measles is the most common vaccine preventable 
cause of death in the world. The World Health 
Organization (WHO) estimates that 8.703 million 
disability adjusted life years (DALY) due to measles 
and 256,000 measles associated deaths still occur 
yearly (1). Developing countries are worst hit (1).  The 
mainstay of measles control is measles vaccine. Since 
1976, the WHO has recommended that measles 
vaccine be integrated into routine health services and 
be administered at nine months of age in developing 
countries (2).  This recommendation was based on 
studies demonstrating seroconversion rates of over 
90% in children nine months of age or older in  
 
developing countries (3).  In Nigeria, measles vaccine 
is also being administered at nine months of age. 
However, 10-15% of measles occur in infants at the 
age of six-eight months, that is, before they can be 
immunized against measles (4).  Therefore, the 
question arises whether administration of measles 
vaccine should be earlier than nine months in order to 
protect this group of infants. Most infants are 
protected against measles by MMA but are 
susceptible to measles when these antibodies fall to 
unprotective levels (3, 5).  As MMA persist in infant, 
measles vaccine cannot be given because these 
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antibodies would interfere with its uptake and 
subsequent seroconversion (5). 
Trans-placental MMA transfer occurs mainly in the 
third trimester of pregnancy and the level of MMA in 
a neonate is directly proportional to gestational age 
(6).  Study of term infants has demonstrated that 
MMA are lost to an unprotective levels by seven 
months of age in developing countries (3, 5). 
Therefore, measles vaccine administered around that 
time, theoretically, would be effective in those infants. 
Keeping in mind that the degree of MMA transfer is 
related to gestational age, preterm infants are likely to 
have lower MMA at birth. Thus, preterm infants are 
likely to become seronegative earlier than term 
infants. This presumably could be due to early 
interruption of intrauterine life associated with 
preterm deliveries. Very few studies have been done 
to verify this hypothesis (7).  If this is so, it stands to 
reason that, preterm infants would require measles 
vaccine earlier and also would seroconvert 
adequately if given measles vaccine at an earlier age 
like term and postterm infants (8).  In view of the 
above, this study was undertaken to estimate and 
compare the levels of MMA in preterm, term and 
postterm infants at birth and six months of age. 
SUBJECTS AND METHODS  
The study was conducted on 19 preterm, 45 term and 
14 postterm infants delivered at the University of 
Maiduguri Teaching Hospital (UMTH), Borno State. 
After clearance from the Medical Research and Ethics 
Committee of UMTH, informed consent from parent 
was obtained. Gestational age at birth was assessed 
from the last menstrual period and ultrasound scan 
reports where available and correlated with the 
Dubowitz criteria (9).  Each infant was allotted a serial 
number at birth. Three millilitres of cord blood was 
collected in a sterile bottle and serum separated by 
centrifugation at 5000 rpm for five minutes. Serum 
samples collected were stored in a refrigerator at -
20°C until the time of MMA assay. Each infant was 
thereafter followed up periodically at the well baby 
clinic. At sixth month of postnatal life, another blood 
sample was collected by venepuncture from each 
infant aseptically and stored in a similar manner as 
above.  
On completion of collection, the samples were 
assayed for MMA using ELISA (Demeditec diagnostic 
Gmbh Kiel Germany) in accordance with the 
manufacturer's instructions.10 Optical densities (OD) 
of reactions in the well plates were read in an 
automated analyzer at 450 nanometre (nm) 
wavelength, MMA titres were obtained by plotting 
graphs of OD against measles IgG concentrations. On 
the basis of manufacturer’s recommendations, 
protective titres for MMA were defined as the levels 
of MMA >12 U/ml, and unprotective titres as levels 
of MMA ≤ 12 U/ml (10). 
Data analysis. Appropriate statistical method was 
used to analyzed the data obtained from this study 
using SPSS statistical software version 16, Illinois, 
Chicago USA. A p value < 0.05 was considered 
significant. Tables were used appropriately for 
illustrations. 
RESULTS 
The study group consisted of 78 newborn infants, out 
of which 40 (51.3 %) were males and 38 (48.7 %) were 
females. The male to female ratio was 1.05: 1. Of these 
newborn infants, 19 (24.4 %) were preterm, 45 (57.7 
%) term and 14 (17.9 %) posterm infants respectively 
(Table 1). Table 2 indicates that 17 (89.5 %) preterm, 
43 (95.6 %) term and 14 (100 %) postterm newborn 
infants at birth had protective MMA. Whereas, two 
(10.5 %) preterm, nine (20.0%) term and two (14.3 %) 
postterm were having protective MMA at six months 
of age. Table 3 shows that the overall comparison of 
mean MMA at birth and at six months of age was 
significant (p = 0.005). However, the comparison of 
mean MMA at birth and at six months of age was 
independent of GA of the infants at birth (p = 0.158) 
and at six months of age (p = 0.83). 
DISCUSSION 
Majority of the preterm, term and all postterm 
newborn infants in this study were found with 
protective levels of MMA at birth. With Preterm 
having lower but protective levels and postterm 
having higher protective MMA than term deliveries. 
This was the observation made in previously 
conducted studies that compared the influence of 
gestational age on MMA in different countries (5-7).  
This may be related to decreased MMA from 
haemodilution, and unequalled transfer of measles 
IgG subclass mostly seen in the first and second 
trimester of pregnancy (11).  Since MMA in foetal 
circulation increases until the time of birth (5, 11),  it 
seems reasonable to assume that these MMA will be 
reduced as gestational age decreases. Also, the 
placentae of infants born before 37 weeks of GA may 
have fewer mature receptors for MMA than those of 
full-term infants (5). All these could lead to lower 
levels of MMA being transported across the placental 
barrier to the foetus. In view of this, some authors 
suggested that GA was the single most important 
factor in transplacental transfer of MMA between 
mother and child (7). 
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 Birth             6 months 
 n ( %)           n ( %) 
 
  Birth             6 months 
  n ( %)           n ( %)               
 
   Birth            6 months 






17 (89.5 %)     2 (10.5 %) 
   
 43 (95.6 %)     9 (20.0%) 
   
 14 (100 %)      2 (14.3 %) 
Unprotective levels 
 
2 (10.5 %)    17 (89.5 %)      2 (4.4 % )      36 (80.0 %)    0 (0 %)         12 (85.7 %) 
MMA=Maternal measles antibodies 
 
TABLE 3. COMPARISON OF GESTATIONAL AGE AND MEAN MATERNAL MEASLES ANTIBODIES AT BIRTH AND SIX     
MONTHS OF AGE 
 
                                            Mean maternal measles antibodies ± SD (U/ml)                                                   
  GA (Weeks)                       Birth                                         Six months                p- value     
    
  Preterm   (<37)                   188.16 ± 87.99                           7.21 ± 5.93                 0.000 
  Term (≥37 <42)                  207.27 ± 77.44                           7.44 ± 8.07                 0.000 
  Post term (≥42)                   239.00 ± 29.90                           8.79 ± 10.01               0.000 
  p- value                              0.158                                         0.830                                                                                    
t = 14.194, p= 0.005 GA= Gestational age 
In the present study, no significant difference was 
noted in the levels of MMA transferred in preterm, 
term and postterm neonates at birth. This is consistent 
with the finding of a study conducted in India (7). 
Therefore; it can be derived that though important, 
GA may not be the only factor affecting tansplacental 
MMA transfer in mother-infant pairs. It is postulated 
that the levels of measles antibody present in a 
mother at the time of delivery besides maternal age 
and nutrition, also depends on measles virus 
exposure and measles vaccine induced immunity (5). 
In this study, it was found that at six months of age, 
89.5%, 80.0% and 85.7% of preterm, term and 
postterm infants were having unprotective MMA. 
This observation corroborated that of other workers 
(7) where the loss of MMA was linked to its normal 
catabolism with the passage of time. The present 
study also found that there is a significant decline of 
mean levels of MMA from birth to six months of age 
in preterm, term and posterm infants, which was 
independent of their GA. This is similar to the 
observation made in Congo where GA of neonates 
did not contribute significantly to the loss of MMA in 
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infancy (12). On the contrary, some authors have 
shown that MMA in neonates at term onward may 
persist throughout the first year of life, only to decline 
to unprotective levels after the first birthday (5). This 
difference may be explained by the fact that the latter 
study was undertaken in developed country, while 
the present study was carried out in a developing 
country, where the loss of MMA have been 
postulated to occur at a faster rate (3, 5, 12). 
Some of the reasons advanced for the early decay of 
MMA in developing countries were sickness and 
repeated blood sampling for diagnostic tests in 
neonates. This results to the removal of measles 
antibody containing plasma and replacement by 
packed red blood cells does not replace the measles 
antibody lost (5). Additionally, the higher incidence of 
infections leads to hyper catabolic state causing faster 
catabolism of MMA in these infants (5).  Cases of 
respiratory tract infections and diarrhoeal diseases 
were reported in some of the infants in this study. 
This could have contributed to the rapid decline of 
MMA in our study population.  
Regarding the optimal age of measles immunization 
of infants in the current study, 89.5%, 80.0% and 
85.7% of preterm, term and posterm infants are likely 
to seroconvert at six months of age. The measles 
vaccination failure rate thus would be 10.5%, 20.0% 
and 14.3% for preterm, term and postterms infants 
respectively. Presently, the vaccination failure rate at 
nine months in developing countries is about 5-10% 
(13). For successful uptake of measles vaccine, two 
conditions should be fulfilled. Firstly, MMA should 
be absent and/or should not interfere with uptake. 
Secondly, the immune system of the patient must be 
capable of mounting an adequate immune response.  
The present study revealed that most of the infants 
lose their MMA by six months of age, with preterm 
infants having the highest percentage. As far as the 
second factor is concerned, Pabst et al (14) have 
pointed out that the capacity to produce antibodies to 
a variety of antigens increases as a function of age. 
Thus, it is possible that an immature immune system 
would cause diminished antibody response to 
measles vaccine in preterm infants. However, a study 
conducted on the response of preterm infants to 
Varicella vaccine have demonstrated that by four 
months of age, the response of preterms was 
comparable to term and postterm infants (15).  This 
comparable immune response can be explained by the 
fact that by virtue of their early exposure to 
extrauterine life, the immune system of a preterm 
neonate matures rapidly and may be capable of 
mounting immunological response required for 
satisfactory uptake of vaccine (8).  Therefore, it is 
quite possible that the measles antibody response to 
measles vaccine given at six months of age would be 
adequate. 
Conclusion  
 A significant decline in transplacentally transmitted 
mean MMA levels was seen in preterm, term and 
postterm infants over a period of six months after 
birth, which was independent of their GA. These 
infants irrespective of their GA are thus prone to 
measles at an earlier age (less than six months). 
Therefore, the current recommendation of 
immunizing infants at nine months of age may 
require reconsideration.  
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